Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is based on positive results from the HERCULES study in adults ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – . Following the press release on October 21, 2024 and the plan to transfer a ...

Autoimmune type 1 diabetes (T1D) is an autoimmune progressive and lifelong condition that can develop regardless of age, lifestyle or family history. Individuals with autoimmune T1D are typically ...

Although presymptomatic T1D (Stages 1 and 2) can be detected months or years before symptoms appear, most people are not diagnosed until they feel unwel. 10 11 Over the past 50 years, scientists ...

Alizée: Lors de mon bilan de santé annuel, mon médecin a remarqué que mon taux de glycémie était légèrement plus élevé qu'il ne devrait l'être. Heureusement, il n'y avait pas de raison immédiate de ...

AI is an incredibly powerful tool that can empower complex data analysis and decision-making. To fully leverage the capabilities of AI, transparency and explainability are required to provide ...

La enfermedad pulmonar obstructiva crónica (EPOC) es la cuarta causa de muerte en todo el mundo, sin embargo, la forma en que tratamos a las personas que viven con esta enfermedad no ha cambiado ...

La transparence et l'explicabilité désignent l'idée que toutes les parties prenantes affectées par le résultat d'un système d'IA devraient pleinement comprendre le fonctionnement interne de ce système ...

A booster to transform breakthrough technologies and processes developed by best-in-class academic partners and start-ups into innovative solutions to accelerate our R&D portfolio. In 2022, the ...